Ngā hua rapu kaituhi :: APM

1

A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers mā Genmin Lu, Pamela B. Conley, Janet M. Leeds, Mark J. Karbarz, Gallia G. Levy, Vandana Mathur, Janice Castillo, Mark Crowther, John T. Curnutte

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity mā Deborah Siegal, John T. Curnutte, Stuart J. Connolly, Genmin Lu, Pamela B. Conley, Brian L. Wiens, Vandana Mathur, Janice Castillo, Michele Bronson, Janet M. Leeds, F. Mar, Alex Gold, Mark Crowther

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa mā Deborah Siegal, Genmin Lu, Janet M. Leeds, Mark J. Karbarz, Janice Castillo, Vandana Mathur, Athiwat Hutchaleelaha, Uma Sinha, Michael M. Kitt, Matt McClure, Stanley J. Hollenbach, John T. Curnutte, Pamela B. Conley, Mark Crowther

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: